PQ203 in Advanced Malignant Tumors Including Triple Negative Breast Cancer

Clinical trial NCT07190469 · RECRUITING

Trial details

NCT number: NCT07190469
Sponsor: ProteinQure Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Triple Negative Breast Cancer (TNBC)Advanced Solid Tumors Cancer

Start date: 2025-09-16
Primary completion: 2028-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.